Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
复制标题
DOI:
10.4049/jimmunol.1001454
复制
发表时间:
2011-06-01
期刊:
影响因子:
--
通讯作者:
Cong Y
中科院分区:
文献类型:
--
作者:
Feng T;Qin H;Wang L;Benveniste EN;Elson CO;Cong Y
Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory bowel disease (IBD) and experimental colitis. However, the complex relationship between Th1 and Th17 cells and their relative contributions to the pathogenesis of IBD have not been completely analyzed. Although it has been recently shown that Th17 cells can convert into Th1 cells, the underlying in vivo mechanisms and the role of Th1 cells converted from Th17 cells in the pathogenesis of colitis are still largely unknown. We report here that Th17 cells from CBir1 TCR transgenic mice, which are specific for an immunodominant microbiota antigen, are more potent than Th1 cells in the induction of colitis, as Th17 cells induced severe colitis, whereas Th1 cells induced mild colitis when transferred into TCRβxδ−/− mice. High levels of IL-12 and IL-23, and substantial numbers of IFNγ+ Th1 cells emerged in the colons of Th17 cell recipients. Administration of anti-IL-17 monoclonal antibody abrogated Th17 cell-induced colitis development, blocked colonic IL-12 and IL-23 production, and inhibited IFNγ+ Th1 cell induction/conversion. IL-17 promoted dendritic cell production of IL-12 and IL-23. Furthermore, conditioned media from colonic tissues of colitic Th17 cell recipients induced IFNγ production by Th17 cells, which was inhibited by blockade of IL-12 and IL-23. Collectively, these data indicate that Th17 cells convert to Th1 cells through IL-17 induction of mucosal innate IL-12 and IL-23 production.
登录
查看更多内容
DOI:
10.1084/jem.20070663
发表时间:
2007-08-06
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Annunziato F;Cosmi L;Santarlasci V;Maggi L;Liotta F;Mazzinghi B;Parente E;Filì L;Ferri S;Frosali F;Giudici F;Romagnani P;Parronchi P;Tonelli F;Maggi E;Romagnani S
通讯作者:
Romagnani S
影响因子:
29.4
作者:
Anderson CA;Massey DC;Barrett JC;Prescott NJ;Tremelling M;Fisher SA;Gwilliam R;Jacob J;Nimmo ER;Drummond H;Lees CW;Onnie CM;Hanson C;Blaszczyk K;Ravindrarajah R;Hunt S;Varma D;Hammond N;Lewis G;Attlesey H;Watkins N;Ouwehand W;Strachan D;McArdle W;Lewis CM;Wellcome Trust Case Control Consortium;Lobo A;Sanderson J;Jewell DP;Deloukas P;Mansfield JC;Mathew CG;Satsangi J;Parkes M
通讯作者:
Parkes M
影响因子:
29.4
作者:
Feng T;Cao AT;Weaver CT;Elson CO;Cong Y
通讯作者:
Cong Y
DOI:
10.1084/jem.20092253
发表时间:
2010-06-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Feng T;Wang L;Schoeb TR;Elson CO;Cong Y
通讯作者:
Cong Y
DOI:
10.1084/jem.20100052
发表时间:
2011-01-17
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Lochner M;Ohnmacht C;Presley L;Bruhns P;Si-Tahar M;Sawa S;Eberl G
通讯作者:
Eberl G